PATENT CLAIM ANALYSIS

Application Number: 15750479
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "050000"]

Abstract:
The present invention relates to salts of anthelmintic compounds with a benzimidazolic structure, such as albendazole (ABZ), fenbendazole (FBZ), triclabendazole (TRBZ), or sulphoxides thereof, flubendazole (FLZ), mebendazole (MBZ), oxibendazole (OBZ), thiabendazole (TBZ), cambendazole (CBZ), parbendazole (PBZ), nocodazole (NCZ), the use thereof and a process for preparation thereof.

Claim (Index 13):
Combination of at least one salt as defined in  claim 1  with at least one antitumour drug and/or proton pump inhibitor, for separate or sequential use in the treatment of tumours.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 88.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15111711', '14440140', '12801853', '10485530', '14085632']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75338383092235
- 35 USC 102 Novelty (BERT): 0.4831391318222667
- Combined Prediction Score: 0.7263593610123417
- Mean Citation Score: 170.215304
- Max Citation Score: 183.41043
- Similarity Product: 133.61511202758192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test